These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 25518495)

  • 1. Standard therapeutic regimens in H. pylori infection leads to activation of transitory fungal flora in gastric mucus.
    Khomeriki S
    Eksp Klin Gastroenterol; 2014; (5):16-20. PubMed ID: 25518495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Yeast-like fungi in the gastric mucus at acid-dependent disease].
    Lazebnik LB; Khomeriki SG; Morozov IA; Kas'ianenko VI; Zvenigorodskaia LA; Khomeriki NM; Goncharenko LS
    Eksp Klin Gastroenterol; 2005; (4):27-32. PubMed ID: 16255534
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of eradication therapy on histological changes in the gastric mucosa in patients with non-ulcer dyspepsia and Helicobacter pylori infection. Prospective randomized intervention study.
    Kyzekova J; Mour J
    Hepatogastroenterology; 1999; 46(27):2048-56. PubMed ID: 10430396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histological and functional recovery in patients with multifocal atrophic gastritis after eradication of Helicobacter pylori infection.
    Savarino V; Mela GS; Zentilin P; Lapertosa G; Bisso G; Mele MR; Pivari M; Mansi C; Vigneri S; Celle G
    Ital J Gastroenterol Hepatol; 1999; 31(1):4-8. PubMed ID: 10091096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the effects of Helicobacter pylori eradication therapy on gastric antral epithelial hyperproliferation: a prospective six-month follow-up study.
    Demiray M; Gulten M; Manavoglu O; Evrensel T; Ulukaya E; Yerci O; Kanat O; Kurt E; Arslan M; Gonullu G; Demiray H; Gulten T; Memik F
    Hepatogastroenterology; 2004; 51(59):1531-5. PubMed ID: 15362794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Course of histological lesions of the gastric mucosa after eradication of H. pylori in patients with duodenal ulcer. Initial study and 6-month follow-up].
    Gisbert JP; Boixeda D; Alvarez Baleriola I; Redondo C; De Rafael L; Martín de Argila C; Hernández Ranz F
    Rev Esp Enferm Dig; 1995 Apr; 87(4):281-7. PubMed ID: 7794634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Helicobacter pylori and different topographic types of gastritis: treatment response after successful eradication therapy in functional dyspepsia.
    Koskenpato J; Färkkilä M; Sipponen P
    Scand J Gastroenterol; 2002 Jul; 37(7):778-84. PubMed ID: 12190090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [State of mucosal barrier of the stomach after Helicobacter pylori eradication and ulcer healing in patients with duodenal ulcer disease].
    Khamraev AA; Rustamova MT; Khaĭrullaeva SS
    Eksp Klin Gastroenterol; 2013; (12):24-6. PubMed ID: 24933985
    [No Abstract]   [Full Text] [Related]  

  • 9. Eradication of Helicobacter pylori infection improved gastric mucosal atrophy and prevented progression of intestinal metaplasia, especially in the elderly population: a long-term prospective cohort study.
    Toyokawa T; Suwaki K; Miyake Y; Nakatsu M; Ando M
    J Gastroenterol Hepatol; 2010 Mar; 25(3):544-7. PubMed ID: 19817964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of melatonin and tryptophan on healing of gastric and duodenal ulcers with Helicobacter pylori infection in humans.
    Celinski K; Konturek PC; Konturek SJ; Slomka M; Cichoz-Lach H; Brzozowski T; Bielanski W
    J Physiol Pharmacol; 2011 Oct; 62(5):521-6. PubMed ID: 22204799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination therapy with clarithromycin and sofalcone for eradication of Helicobacter pylori.
    Kodama R; Fujioka T; Fujiyama K; Kawasaki H; Kubota T; Nasu M
    Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S125-8. PubMed ID: 7735929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A four-year follow-up of duodenal ulcer patients after Helicobacter pylori eradication.
    Tepes B; Kavcic B; Gubina M; Krizman I
    Hepatogastroenterology; 1999; 46(27):1746-50. PubMed ID: 10430336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Helicobacter pylori eradication improves gastric histology and decreases serum gastrin, pepsinogen I and pepsinogen II levels in patients with duodenal ulcer.
    Pimanov SI; Makarenko EV; Voropaeva AV; Matveenko ME; Voropaev EV
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1666-71. PubMed ID: 17559360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Normalization of pH level and gastric mucosa after eradication of H. pylori in the remnant stomach.
    Kato S; Matsukura N; Matsuda N; Tsuchiya S; Naito Z; Tajiri T
    J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S258-61. PubMed ID: 19120908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of cure of Helicobacter pylori infection on gastric acidity and gastroesophageal reflux: study by 24-h pH monitoring in patients with gastric or duodenal ulcer.
    Fukuchi T; Ashida K; Yamashita H; Kiyota N; Tsukamoto R; Takahashi H; Ito D; Nagamatsu R
    J Gastroenterol; 2005 Apr; 40(4):350-60. PubMed ID: 15870971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of co-existence of Helicobacter pylori and Candida fungi in diseases of the upper gastrointestinal tract.
    Karczewska E; Wojtas I; Sito E; Trojanowska D; Budak A; Zwolinska-Wcislo M; Wilk A
    J Physiol Pharmacol; 2009 Dec; 60 Suppl 6():33-9. PubMed ID: 20224149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination therapy with mucosal protective agent for the eradication of Helicobacter pylori.
    Fukuda Y; Yamamoto I; Okui M; Tonokatsu Y; Tamura K; Shimoyama T
    Eur J Gastroenterol Hepatol; 1995 Aug; 7 Suppl 1():S45-7. PubMed ID: 8574735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sofalcone, a gastroprotective drug, promotes gastric ulcer healing following eradication therapy for Helicobacter pylori: a randomized controlled comparative trial with cimetidine, an H2-receptor antagonist.
    Higuchi K; Watanabe T; Tanigawa T; Tominaga K; Fujiwara Y; Arakawa T
    J Gastroenterol Hepatol; 2010 May; 25 Suppl 1():S155-60. PubMed ID: 20586860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Eradication of Helicobacter pylori possibly followed by gastroesophageal reflux disease].
    Loffeld RJ
    Ned Tijdschr Geneeskd; 1999 Dec; 143(50):2505-7. PubMed ID: 10627750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eradication therapy of Helicobacter pylori directly induces apoptosis in inflammation-related immunocytes in the gastric mucosa--possible mechanism for cure of peptic ulcer disease and MALT lymphoma with a low-grade malignancy.
    Ohara T; Kanoh Y; Higuchi K; Arakawa T; Morisita T
    Hepatogastroenterology; 2003; 50(51):607-9. PubMed ID: 12828043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.